Cargando…

Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody

Ricin is regarded as a high terrorist risk for the public due to its high toxicity and ease of production. Currently, there is no therapeutic or vaccine available against ricin. D9, a murine monoclonal antibody developed previously in our laboratory, can strongly neutralize ricin and is therefore a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Wei-Gang, Yin, Junfei, Chau, Damon, Negrych, Laurel M., Cherwonogrodzky, John W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458913/ https://www.ncbi.nlm.nih.gov/pubmed/23049820 http://dx.doi.org/10.1371/journal.pone.0045595

Ejemplares similares

Conformation-Dependent High-Affinity Potent Ricin-Neutralizing Monoclonal Antibodies
por: Hu, Wei-Gang, et al.
Publicado: (2013)

Active Immunity Induced by Passive IgG Post-Exposure Protection against Ricin
por: Hu, Charles Chen, et al.
Publicado: (2014)

Sub-Domains of Ricin’s B Subunit as Targets of Toxin Neutralizing and Non-Neutralizing Monoclonal Antibodies
por: Yermakova, Anastasiya, et al.
Publicado: (2012)

Ricin Antibodies’ Neutralizing Capacity against Different Ricin Isoforms and Cultivars
por: Orsini Delgado, Maria Lucia, et al.
Publicado: (2021)

A Humanized Monoclonal Antibody Cocktail to Prevent Pulmonary Ricin Intoxication
por: Rong, Yinghui, et al.
Publicado: (2020)

Sites of vulnerability on ricin B chain revealed through epitope mapping of toxin-neutralizing monoclonal antibodies
por: Vance, David J., et al.
Publicado: (2020)

Neutralizing Monoclonal Antibodies against Disparate Epitopes on Ricin Toxin’s Enzymatic Subunit Interfere with Intracellular Toxin Transport
por: Yermakova, Anastasiya, et al.
Publicado: (2016)

Crystal Structure and Computational Modeling of the Fab Fragment from a Protective Anti-Ricin Monoclonal Antibody
por: Zhao, Zhiyu, et al.
Publicado: (2012)

Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
por: Pelat, Thibaut, et al.
Publicado: (2009)

Characterization of Neutralizing Human Anti-Tetanus Monoclonal Antibodies Produced by Stable Cell Lines
por: Manieri, Tania Maria, et al.
Publicado: (2022)

Improving the biophysical properties of anti-ricin single-domain antibodies()
por: Turner, Kendrick B., et al.
Publicado: (2015)

In silico prediction of the neutralization range of human anti-HIV monoclonal antibodies
por: Shmelkov, E, et al.
Publicado: (2012)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B
por: Drozdowski, Brian, et al.
Publicado: (2010)

A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability
por: Chen, Lei, et al.
Publicado: (2023)

Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms
por: Bedinger, Daniel, et al.
Publicado: (2015)

Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins
por: Czajka, Timothy F., et al.
Publicado: (2022)

Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin
por: Roy, Chad J., et al.
Publicado: (2020)

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin toxin B chain.
por: Embleton, M. J., et al.
Publicado: (1991)

Isolation of Anti-Ricin Protective Antibodies Exhibiting High Affinity from Immunized Non-Human Primates
por: Noy-Porat, Tal, et al.
Publicado: (2016)

Structural Insights into the Neutralization Properties of the Fully Human, Anti-interferon Monoclonal Antibody Sifalimumab
por: Oganesyan, Vaheh, et al.
Publicado: (2015)

Targeting human vasohibin‐2 by a neutralizing monoclonal antibody for anti‐cancer treatment
por: Koyanagi, Takahiro, et al.
Publicado: (2017)

Routing of internalized ricin and ricin conjugates to the Golgi complex
Publicado: (1986)

Generation of Highly Efficient Equine-Derived Antibodies for Post-Exposure Treatment of Ricin Intoxications by Vaccination with Monomerized Ricin
por: Falach, Reut, et al.
Publicado: (2018)

Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
por: Liu, Ling, et al.
Publicado: (2016)

Preclinical characterization of an anti-methamphetamine monoclonal antibody for human use
por: Stevens, Misty W, et al.
Publicado: (2014)

Humanization and Characterization of an Anti-Human TNF-α Murine Monoclonal Antibody
por: Chiu, Wei-Chun, et al.
Publicado: (2011)

Methods to Characterize Ricin for the Development of Reference Materials
por: Kim, Sook-Kyung, et al.
Publicado: (2006)

Antibody-Mediated Inhibition of Ricin Toxin Retrograde Transport
por: Yermakova, Anastasiya, et al.
Publicado: (2014)

Broad neutralization of SARS-related viruses by human monoclonal antibodies
por: Wec, Anna Z., et al.
Publicado: (2020)

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide
Publicado: (1993)

Computational Prediction of Neutralization Epitopes Targeted by Human Anti-V3 HIV Monoclonal Antibodies
por: Shmelkov, Evgeny, et al.
Publicado: (2014)

Immunotherapy of SARS based on combinations of neutralizing human monoclonal antibodies
por: Du, Lanying, et al.
Publicado: (2010)

Novel neutralizing human monoclonal antibodies against tetanus neurotoxin
por: Minamitani, Takeharu, et al.
Publicado: (2021)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

Characterization of Co-Formulated High-Concentration Broadly Neutralizing Anti-HIV-1 Monoclonal Antibodies for Subcutaneous Administration
por: Sharma, Vaneet K., et al.
Publicado: (2020)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas
por: Tsang, Kwong yok, et al.
Publicado: (2022)

A novel human anti-interleukin-1β neutralizing monoclonal antibody showing in vivo efficacy
por: Goh, Angeline XH, et al.
Publicado: (2014)

Spatial location of neutralizing and non-neutralizing B cell epitopes on domain 1 of ricin toxin’s binding subunit
por: Rong, Yinghui, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rhl9v451asoqtuinose1ot10t4